In Vero E6 cells, Simeprevir yielded an EC50 of 4.08 μM based on SARS-CoV-2 ORF1b copy number in culture supernatant, with DMSO as the negative control. In a separate comparison, 10 μM Simeprevir inhibited SARS-CoV-2 antigen expression relative to its absence. Cell viability measurements in Vero E6 cells yielded a CC50 of 19.33 μM. [1,2]
Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.
Antiviral activity in Vero E6 cells
Cell-based study · Vero E6 [1]
Vero E6 cells received varying concentrations of Simeprevir, with DMSO as the negative control. Quantification of SARS-CoV-2 ORF1b copy number in culture supernatant yielded an EC50 of 4.08 μM.
Literature-Reported Treatment Conditions
- Treatment concentration
- varying concentrations
- Exposure duration
- 1 h before infection, during infection, and 48 h after infection
- Method
- present in the supernatant
- Vehicle
- DMSO
- Co-treatment
- Other interventions in this design: SCoV2 multiplicity of infection (MOI) of 0.05. Compound effect isolated by the comparison: DMSO as the vehicle was used as a negative control.
Methods and source locations
Compound reported in the paper: Simeprevir
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Results > Prioritized Screening Identifies Simeprevir As a Potent Suppressor of SARS-CoV-2 Replication in a Cellular Infection Model (S4, S6); Materials and Methods > In Vitro SARS-CoV-2 Antiviral Tests (S44, S45, S46, S47); Materials and Methods > In Vitro PLpro Inhibition Assay—Fluorescence-Based (S94); Figure 2 legend (S129)
quantification of SARS-CoV-2 ORF1b copy number in the culture supernatant: quantification of SARS-CoV-2 ORF1b copy number in the culture supernatant; comparator: DMSO as the vehicle was used as a negative control — Results > Prioritized Screening Identifies Simeprevir As a Potent Suppressor of SARS-CoV-2 Replication in a Cellular Infection Model (S6); Materials and Methods > In Vitro SARS-CoV-2 Antiviral Tests (S47)
Viral antigen expression in Vero E6 cells
Cell-based study · Vero E6 cells [2]
Vero E6 cells were exposed to SARS-CoV-2 in the presence or absence of 10 μM Simeprevir. Simeprevir inhibited the expression of SARS-CoV-2 antigens.
Literature-Reported Treatment Conditions
- Treatment concentration
- 10 μM
- Exposure duration
- 24 h
- Method
- SARS-CoV-2 virus was then added to the cells in the presence or absence of 10 μM simeprevir.
- Vehicle
- dimethyl sulfoxide (DMSO)
- Co-treatment
- Other interventions in this design: SARS-CoV-2 MOI of 0.01. Compound effect isolated by the comparison: in the presence or absence of 10 μM simeprevir.
Methods and source locations
Compound reported in the paper: Simeprevir
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Materials and methods > Cells, compounds and virus (S3); Materials and methods > Immunofluorescence assay (S24, S25, S26, S27, S28, S29, S30); Fig. 1 legend (S51)
expression of SARS-CoV-2 antigens: expression of SARS-CoV-2 antigens; comparator: absence of 10 μM simeprevir — Materials and methods > Immunofluorescence assay (S24)
Cytotoxicity in Vero E6 cells
Cell-based study · Vero E6 cells [1]
Vero E6 cells received Simeprevir at the indicated concentrations. Cell viability measured by colorimetric absorbance yielded a CC50 of 19.33 μM.
Literature-Reported Treatment Conditions
- Treatment concentration
- indicated concentrations
- Exposure duration
- 48 h
- Vehicle
- DMSO
- Reported limits
- Not stated in the sentences used: route, control.
Methods and source locations
Compound reported in the paper: Simeprevir
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Results > Prioritized Screening Identifies Simeprevir As a Potent Suppressor of SARS-CoV-2 Replication in a Cellular Infection Model (S6); Materials and Methods > Chemicals and Reagents (S41); Materials and Methods > In Vitro Drug Cytotoxicity Assays (S62, S63, S64)
Cell viability was quantified with colorimetric absorbance at 590 nm: Cell viability was quantified with colorimetric absorbance at 590 nm — Results > Prioritized Screening Identifies Simeprevir As a Potent Suppressor of SARS-CoV-2 Replication in a Cellular Infection Model (S6); Materials and Methods > In Vitro Drug Cytotoxicity Assays (S64)